Conduction System Pacing in Pediatric Patients
JACC: Clinical Electrophysiology · 2026-11
DOI: 10.1016/j.jacep.2026.10.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2026-11. Verfasst von Óscar Cano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitari i Politècnic La Fe, Valencia, Spain; Instituto de Investigación Sanitaria La Fe, Valencia, Spain; Centro de Investigaciones Bio…. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Conduction system pacing (CSP) may be advantageous in children requiring lifelong ventricular pacing, but long-term durability data are limited. OBJECTIVES: The goal of this study was to evaluate the long-term preservation, durability, and safety of CSP in pediatric patients. METHODS: This international, multicenter, retrospective study included consecutive patients aged ≤18 years undergoing His bundle pacing or left bundle branch area pacing at 9 experienced centers. The primary endpoint was long-term preservation of CSP. RESULTS: Among 120 patients (mean age 12.6 ± 3.7 years), 68 (56.7%) had congenital atrioventricular block, 41 (34.2%) had congenital heart disease, and 12 (10.0%) underwent CSP for heart failure/cardiac resynchronization therapy (CRT). Acute CSP implantation, defined as achievement of His bundle pacing, left bundle branch pacing, or left ventricular septal pacing, was successful in 116 patients (96.7%). After a median follow-up of 24 months (Q1-Q3: 10-54 months), electrical lead performance remained stable. Among 101 patients with CSP at implantation and follow-up capture assessment, CSP was preserved in 95 (94.1%). Kaplan-Meier-estimated freedom from loss of CSP was 100.0% at 1 year and 98.2% (95% CI: 94.7%-100.0%) at 2 and 3 years. CSP lead-related complications occurred in 10 patients (8.3%), and reintervention was required in 9 (7.5%). In the CRT subgroup, left ventricular ejection fraction improved from 28.8% ± 9.4% to 46.8% ± 12.0% (P < 0.001). CONCLUSIONS: CSP is a feasible, safe, and durable physiological pacing strategy in children, with excellent long-term CSP preservation and stable electrical performance despite ongoing somatic growth. CSP may also provide effective physiological resynchronization in pediatric patients requiring CRT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Universitari i Politècnic La Fe, Valencia, Spain; Instituto de Investigación Sanitaria La Fe, Valencia, Spain; Centro de Investigaciones Biomédicas en RED en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spa…
- Interventional Arrhythmology Department, "University Medical Center" Corporate Fund, Astana, Kazakhstan.
- Cardiology Department, University Medical Centre Ljubljana, Ljubljana, Slovenia.
- Velammal Medical College Hospital and Research Institute, Madurai, Tamil Nadu, India.
- Clinic for Electrophysiology, Herz-Und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
- Department of Cardiology, University Hospital Antwerp, Edegem, Belgium; Department GENCOR-Heart Rhythm Disorders, University of Antwerp, Antwerp, Belgium.
Zitieren
APA
Cano, Ó., Turubayev, Y., Žižek, D., Ponnusamy, S. S., Imnadze, G., Huybrechts, W., Vijayaraman, P., Molina-Lerma, M., de Wilde, H., Nuralinov, O., Ruiz, E., & de Pooter, J. (2026). Conduction System Pacing in Pediatric Patients. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2026.10.010
Vancouver
Cano Ó, Turubayev Y, Žižek D, Ponnusamy SS, Imnadze G, Huybrechts W, et al. Conduction System Pacing in Pediatric Patients. JACC: Clinical Electrophysiology. 2026. doi:10.1016/j.jacep.2026.10.010
BibTeX
@article{Cano2026,
author = {Cano, Óscar and Turubayev, Yerlan and Žižek, David and Ponnusamy, Shunmuga Sundaram and Imnadze, Guram and Huybrechts, Wim and Vijayaraman, Pugazhendhi and Molina-Lerma, Manuel and de Wilde, Hans and Nuralinov, Omirbek and Ruiz, Eladio and de Pooter, Jan},
title = {Conduction System Pacing in Pediatric Patients},
journal = {JACC: Clinical Electrophysiology},
year = {2026},
doi = {10.1016/j.jacep.2026.10.010}
}
EUVIMED